Mller TD, Blher M, Tschp MH, et al
Its often celebrated for its ability to boost energy levels, support cognitive function, and promote a healthy nervous system
Extra-intestinal manifestationssuch as arthritis, skin lesions, and eye inflammationmay also occur
The Clinical Data: Everything Published So Far Phase 1 First-in-Human (Oral Formulation) Published: The Lancet, June 2025 Participants: 144 adults with overweight or obesity (BMI 25.039.9), no diabetes Duration: Up to 12 weeks Dosing: Once-daily oral amycretin, up to 2 50 mg Results: - 50 mg dose: 10.4% mean body weight change - 2 50 mg dose: 13.1% mean body weight change - Placebo: 1.2% 13% weight loss in 12 weeks
Pinch the skin, insert the needle at a 4590 degree angle, and slowly push the plunger to deliver the full dose